A Versatile and Scalable Platform That Streamlines Data Collection for Patient-Centered Studies: Usability and Feasibility Study

BACKGROUND: The Food and Drug Administration Center for Biologics Evaluation and Research (CBER) established the Biologics Effectiveness and Safety (BEST) Initiative with several objectives, including the expansion and enhancement of CBER’s access to fit-for-purpose data sources, analytics, tools, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Haley, Aschettino, Sofia, Lari, Nasim, Lee, Ting-Hsuan, Rosenberg, Sarah Stothers, Ng, Xinyi, Muthuri, Stella, Bakshi, Anirudh, Bishop, Korrin, Ezzeldin, Hussein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520400/
https://www.ncbi.nlm.nih.gov/pubmed/36103218
http://dx.doi.org/10.2196/38579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520400/
https://www.ncbi.nlm.nih.gov/pubmed/36103218
http://dx.doi.org/10.2196/38579

Ejemplares similares